Concepedia

Sarah Kelly

SK

20

Publications

990

Citations

17

H-Index

2000

Active since

Affiliations

University of Oxford(Current)

Oxford BioMedica (United Kingdom)

Patan Academy of Health Sciences

University of Otago

Novartis (Italy)

Sarah Kelly is an author at University of Oxford specializing in medicine, vaccination, and vaccine efficacy.

ORCID

Top concepts

Publications per year

2000–2024

20

Publications

20

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Amy Flaxman, Natalie G. Marchevsky, Daniel Jenkin et al. · The Lancet · 2021 · 253 citations · Full text

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial

Firdausi Qadri, Farhana Khanam, Xinxue Liu et al. · The Lancet · 2021 · 145 citations · Full text

Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

Mila Shakya, Merryn Voysey, Katherine Theiss-Nyland et al. · The Lancet Global Health · 2021 · 96 citations · Full text

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

Matthew D. Snape, Praveen Saroey, Tessa M. John et al. · Canadian Medical Association Journal · 2013 · 78 citations · Full text

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R. W. Emary et al. · Nature Communications · 2021 · 52 citations · Full text

Rows per page

1–5 of 20